Interview with Dr. Gary Wu: Studying bacterial metabolites may lead to new treatments for IBD
Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education.
Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education. His research examines interactions between gut microbiota and host, particularly focusing on diet and metabolism.
Dr. Wu gave a talk at Experimental Biology 2015 called, “Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease“.
Visit our Gut Microbiota for Health Youtube video channel for more expert interviews!
Also be sure to download our Gut Microbiota & Inflammatory Bowel Disease (IBD) Best of document.
Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014. Find her on: Google • Twitter
2025 has been a productive year in gut microbiome research, spanning metabolic health, neurogastroenterology, immune modulation, and precision nutrition. In this ‘Year in Review’ article, the GMFH editing team describes their pick of the top GMFH-covered advances in 2025, outlining their impact in the clinical setting and implications for current and future research.
The definition of a prebiotic has evolved from a focus on colonic fiber to a complex ecological strategy. This article traces the concept's 30-year journey, highlighting the shift from non-digestible carbohydrates to the latest expert recommendations.
Cardiovascular diseases remain one of the most pressing public health concerns, demanding innovative research to identify novel causes. A recent Nature study reported that imidazole propionate made by gut bacteria contributes to atherosclerosis development, supporting its potential role as a biomarker of subclinical disease.
